Gene · 2235
Papers1,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prime Real Estate: Metals, Cofactors and MICOS. | Front Cell Dev Biol | 2022 | 35669513 | PubTator, text mining | PubMed |
| Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges. | Front Pharmacol | 2022 | 35668934 | PubTator, text mining | PubMed |
| Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing Gliomas. | Front Med (Lausanne) | 2022 | 35665365 | PubTator, text mining | PubMed |
| The application of fluorescein sodium for the resection of medulloblastoma. | J Neurooncol | 2022 | 35657459 | PubTator, text mining | PubMed |
| Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis. | Sci Rep | 2022 | 35650387 | PubTator, text mining | PubMed |
| Ferrochelatase: Mapping the Intersection of Iron and Porphyrin Metabolism in the Mitochondria. | Front Cell Dev Biol | 2022 | 35646904 | PubTator, text mining | PubMed |
| Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma. | J Hepatol | 2022 | 35636578 | PubTator, text mining | PubMed |
| Hemoglobin Endocytosis and Intracellular Trafficking: A Novel Way of Heme Acquisition by Leishmania. | Pathogens | 2022 | 35631106 | PubTator, text mining | PubMed |
| Glucose-Related Traits and Risk of Migraine-A Potential Mechanism and Treatment Consideration. | Genes (Basel) | 2022 | 35627115 | PubTator, text mining | PubMed |
| Fluorescence-Guided Surgery in Glioblastoma: 5-ALA, SF or Both? Differences between Fluorescent Dyes in 99 Consecutive Cases. | Brain Sci | 2022 | 35624942 | PubTator, text mining | PubMed |
| Genomic analyses of 10,376 individuals in the Westlake BioBank for Chinese (WBBC) pilot project. | Nat Commun | 2022 | 35618720 | PubTator, text mining | PubMed |
| Al2O3-MgO Supported Ni, Mo, and NiMo Mixed Phosphidic-Sulphidic Phase for Hydrotreating of Stearic and Oleic Acids Into Green Diesel. | Front Chem | 2022 | 35615310 | PubTator, text mining | PubMed |
| Response of Iron Deficiency Markers to Blood Lead Levels and Synergistic Outcomes at Prenatal Stage. | Dose Response | 2022 | 35602584 | PubTator, text mining | PubMed |
| Impact of Levetiracetam Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1 Wild-Type Glioblastoma. | Cancers (Basel) | 2022 | 35565263 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
| Clinical-Pathological Conference Series from the Medical University of Graz : Case No 125: A 42-year-old man with loss of appetite, vomiting and stabbing abdominal pain. | Wien Klin Wochenschr | 2022 | 35543823 | PubTator, text mining | PubMed |
| The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside. | J Ginseng Res | 2022 | 35509820 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Iron and Heme Metabolism. | Annu Rev Nutr | 2022 | 35508203 | PubTator, text mining | PubMed |
| Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target. | Nat Chem Biol | 2022 | 35484434 | PubTator, text mining | PubMed |
| Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437. | ACS Chem Biol | 2022 | 35482948 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2235/papers?page=19